Table 1.

Correlation of clinicopathological and demographic parameters of CRC patients with PD-L1 and PD-L2 expression

Parameters	No. of cases	Percentage (%)	PD-L1 expression Low High			P values
Total	91	100	38 (41.8%)		53 (58.2%)
Gender Male Female	51 40	56.0 44.0	21 (23.1%) 17 (18.7%)		30 (30.0%) 23 (25.3%)	0.534
Age <65 >65	41 50	45.1 54.9	17 (18.7%) 21 (23.1%)		24 (26.0%) 29 (31.9%)	0.565
Stage I + II III + IV	49 42	53.8 46.2	29 (31.9%) 9 (9.9%)		20 (22.0%) 33 (36.3%)	0.0001
Parameters	No. of cases	Percentage (%)	PD-L2 expression Low High			P values
Total	91	100	69 (75.8%)	22 (24.2%)
Gender Male Female	51 40	56.0 44.0	39 (42.9%) 30 (33.0%)	12 (13.2%) 10 (11.0%)		0.531
Age <65 >65	41 50	45.1 54.9	31 (34.1%) 38 (41.8%)	10 (11.0%) 12 (13.2%)		0.579
Stage I + II III + IV	49 42	53.8 46.2	37 (40.7%) 32 (35.9%)	12 (13.2%) 10 (11.0%)		0.569

P values are based on the frequency of PD-L1 and PD-L2 expression within each parameter